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Whole-body energy metabolism is regulated by the hypothalamus
and has an impact on diverse tissue functions. Here we show that
selective knockdown of Sirtuin 1 Sirt1 in hypothalamic Agouti-re-
lated peptide-expressing neurons, which renders these cells less
responsive to cues of low energy availability, signiﬁcantly pro-
motes CD4+ T-cell activation by increasing production of T helper
1 and 17 proinﬂammatory cytokines via mediation of the sympa-
thetic nervous system. These phenomena were associated with an
impaired thymic generation of forkhead box P3 (FoxP3+) naturally
occurring regulatory T cells and their reduced suppressive capacity in
the periphery, which resulted in increased delayed-type hypersensi-
tivity responses and autoimmune disease susceptibility in mice. These
observations unmask a previously unsuspected role of hypothalamic
feeding circuits in the regulation of adaptive immune response.
immune system | sirtuins
Hypothalamic Agouti-related peptide-expressing (AgRP)neurons aremandatory for feeding and survival (1, 2) and they
mediate effects of the hystone deacetylase Sirtuin 1 (Sirt1) on
energymetabolism (3, 4). Behavioral andmetabolic adaptations to
low energy availability are enabled by AgRP neurons, but it is
unknown whether these neurons are involved in the regulation of
other tissue functions key to survival, such as adaptive immune
responses. Sirtuins are NAD+-dependent class-III deacetylases
that are highly conserved across species (5). Nutrient deprivation
up-regulates Sirt1 in several tissues (6, 7), which is important for
the metabolic shift that occurs during negative energy balance (8),
a metabolic state in which energy expenditure is higher than en-
ergy intake. Evidence suggests that the effects of sirtuins may
mediate the beneﬁcial effects of calorie restriction, the only known
physiological intervention that promotes a longer, healthier life-
span across species (9–14). However, the site of action of sirtuins
in these physiological processes remains ill-deﬁned.
The CNS was previously recognized as an immune-privileged
site with lack of immunosurveillance. However, accumulating ev-
idence has shown that a mutual interaction between the immune
system and CNS exists both in physiological and pathological sit-
uations (15). The CNS inﬂuences and controls the immune system
at least partly through the autonomic nervous system (15). Lym-
phocytes express the receptors for different neurotransmitters,
which enable the brain to properly coordinate the immune system
and to maintain the homeostasis of the whole body by responding
to environmental changes, such as infections, in an appropriate
manner. In this context, we and others have shown that nutritional
status can affect T helper 1 (Th1) proinﬂammatory immune re-
sponses through a series of adipose-tissue-derived hormones in-
cluding leptin, which mediates its effects on immune cells either
directly by activating leptin receptors on T cells or indirectly by its
effect on autonomic nervous system.
Recent studies have shown that Sirt1 negatively regulates
T-cell activation and plays a major role in clonal T-cell anergy in
mice. Up-regulation of Sirt1 expression led to T-cell anergy by
diminishing the activity of the transcription factor activator
protein 1, through the deacetylation of c-Jun (16).
Conversely, Sirt1-deﬁcient mice were unable to maintain T-cell
tolerance and developed severe experimental autoimmune enceph-
alomyelitis (EAE) aswell as spontaneous autoimmunity, and treating
them with resveratrol (a strong activator of Sirt1) led to decreased
disease symptoms as well as inﬂammatory cell inﬁltration in the CNS
(16). As mentioned above, selective knockdown of Sirt1 in hypo-
thalamic AgRP neurons alters the central perception of hunger, in-
ducing a series of metabolic/behavioral adaptations that resemble
those of a satiety phenotype despite reduced food intake and body fat
mass (4). Thus, in this study we aimed to determine whether selective
ablation of Sirt1 expression in AgRP neurons affects peripheral
adaptive immunity by analyzing lymphoid organs’ immune pheno-
type, thymic selection, in vitro/in vivo regulatory/proinﬂammatory
immune responses, and autoimmune disease susceptibility in mice.
Results
Altered Generation of Thymus-Derived, Naturally Occurring Regulatory
T Cells in AgRP-Sirt1 Knockout Mice. First we compared the basal
immunophenotype of the thymus, bone marrow, lymph nodes,
and spleen obtained from AgRP-Sirt1 KO mice and their litter-
mate controls. Sirt1 was equally expressed in highly puriﬁed
T-cell subsets (effector and regulatory T cells) in experimental
and control mice, and its knockout was selective for AgRP neu-
rons (Fig. S1). No signiﬁcant differences were observed either
in basal immune phenotypes or activation markers of the bone
marrow, lymph nodes, and spleen of naïve unimmmunized AgRP-
Sirt1 KO mice (Figs. S2–S8). However, signiﬁcant differences
were detected in the thymus (Fig. 1). AgRP Sirt1 knockout (KO)
mice displayed a more “immature” thymic phenotype: Quantiﬁ-
cation of CD4- and CD8-positive cells revealed a signiﬁcant in-
crease in the percentage of double-negative (DN) thymocytes in
AgRP Sirt1 KO mice, although the total number of thymocytes
was not reduced (Fig. 1 A–C). We also observed a signiﬁcant
reduction in the percentage of double-positive (DP) CD4+CD8+
thymocytes, indicating a potential impairment at the DN-to-DP
transition in AgRP-Sirt1 KO mice. Next, we found that AgRP-
Sirt1 KO mice displayed a signiﬁcantly lower percentage of thy-
mic CD4+FoxP3+ naturally occurring regulatory T (Treg) cells
compared with control values (Fig. 1D). This difference was
associated with impairment in the in vivo proliferation of thymus-
derived Treg cells shown by signiﬁcantly reduced ex vivo expres-
sion of the proliferating cell nuclear antigen (PCNA) in AgRP-
Sirt1 KO mice. Because we have previously shown that the
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mammalian target of rapamycin (mTOR) kinase plays a key role
in the metabolic control of Treg cell responsiveness (17–20), we
also analyzed S6 phosphorylation levels, a measure of mTOR path-
way activity in the thymic Treg cell subset. In accordance with
previous ﬁndings, impaired in vivo proliferation of thymic Treg
cells in the AgRP-Sirt1 KO mice was associated with lower activity
of mTOR pathway compared with controls (Fig. 1 D and F). Con-
versely, upon in vitro stimulation, Treg cells from AgRP-Sirt1 KO
mice were not “classically anergic” like their control littermates,
because they showed a lower proliferative proﬁle in vivo and a
reduced anergy in vitro upon CD3/CD28 stimulation (Fig. 1E).
AgRP-Sirt1 KO Mice Display Increased Activation of CD4+ T Cells upon
in Vivo Antigen Challenge. We next analyzed peripheral adaptive
immune responses of CD4+ T cells in immunized mice primed
with complete Freund’s adjuvant (CFA). Surprisingly, lymph
node-derived T cells from AgRP-Sirt1 KO mice proliferated
more robustly upon T-cell receptor (TCR)-mediated stimulation
(with anti-CD3e and 2C11 mAb) than those from their littermate
controls (Fig. 2A). The increased proliferative proﬁle of these
cells in AgRP-Sirt1 KO mice was associated with signiﬁcantly
higher proinﬂammatory cytokine production compared with
control values, including IL-2, IL-6, IL-17, IFN-γ, and TNF-α,
whereas secretion of IL-4 and IL-5, both anti-inﬂammatory
cytokines, was signiﬁcantly lower, and there was also a tendency
to decrease the amount of IL-10 (Fig. 2B) in the KO mice. These
cytokine proﬁles correlated with the expression of cell-surface
activation markers on CD4+ T cells from control and AgRP-Sirt1
KO mice. The expression of activation markers such as CD25,
CD54, and CD49d was signiﬁcantly higher, together with their
increased induction, upon TCR-mediated activation in AgRP-
Sirt1 KO mice compared with controls (Fig. 2C). Finally, the
molecular signaling analysis of the early activation events re-
vealed an enhanced phosphorylation of ERK1/2 and S6, as well
as a concomitantly more pronounced degradation of the cyclin-
dependent kinase inhibitor p27Kip1 in T cells from AgRP-Sirt1
KO mice compared with controls (Fig. 2D).
AgRP-Sirt1 KO Mice Display a Discordant Suppressive Function of
Naturally Occurring Treg Cells. To address whether these func-
tional alterations in terms of increased proinﬂammatory activity
in CD4+ T cells was functionally related to an impairment in
naturally occurring FoxP3+ Treg cell number and function, we
next analyzed peripheral lymph node-derived Treg cell compart-
ments in antigen-challenged (immunized with CFA)mice. Ex vivo
analysis of Treg cells in these animals revealed that AgRP-Sirt1
KO mice displayed an impairment in their homeostatic pro-
liferation, as shown by reduced expression of PCNA in the lymph
nodes (Fig. 3A). This phenomenon was accompanied by a reduced
activity of the mTOR pathway (assessed as S6 phosphorylation),
indicating an altered metabolic control of Treg cell proliferation
in AgRP-Sirt1 KOmice (Fig. 3A). Interestingly, these phenomena
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Fig. 1. Thymic phenotype and effects of selective ablation of
Sirt1 in Agrp neurons in the generation of thymic-derived
naturally occurring Treg cells. (A) Morphology of thymus from
WT and AgRP-Sirt1 KO mice. (B) Cell numbers of thymocytes in
WT (black columns) and AgRP-Sirt1 KO (gray columns) mice.
Data are shown as mean ± SD (n = 5 mice/group). (C) CD4 and
CD8 expression in the thymus from WT and AgRP-Sirt1 KO
mice. One representative out of three independent experi-
ments. (D) Ex vivo analysis of the percentage of Treg, PCNA,
and S6 expression in Treg cells from the thymus of WT and
AgRP-Sirt1 KO mice. (n = 3 mice/group, one representative out
of three independent experiments). (E) Percentage of BrdU-
positive cells upon anti-CD3/CD28 stimulation in thymic-de-
rived Treg cells from WT (black column) and AgRP-Sirt1 KO
(gray column) mice. The data are shown as mean ± SD (n =
5 mice/group; *P < 0.001). (F ) Immunoblot for P-S6 and its
relative densitometric quantiﬁcation in puriﬁed thymic-
derived Treg cells from WT (black column) and AgRP-Sirt1 KO
(gray column) mice. One representative out of three indepen-
dent experiments.
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were revealed upon CFA immunization and were not observed in
naïve AgRP-Sirt1 KO mice (Fig. S5). At a functional level we
observed a “discordant” suppressive capacity in Treg cells from
AgRP-Sirt1 KO mice; they were able to suppress proliferation of
CD4+CD25−FoxP3−T-effector (Teff) cells evaluated as thymidine
incorporation (Fig. S9 and Fig. 3B) but associated with a reduced
capacity to suppress proinﬂammatory cytokine production by Teff.
As shown in Fig. 3B, IL-2, IL-17, and IFN-γ produced by Teff cells
were not inhibited by Treg cells from AgRP-Sirt1 KO mice com-
pared with littermate controls (Fig. 3B and Fig. S9). To address the
molecular mechanism linking the altered neuronal activity with the
peripheral immune phenotype observed in AgRP-Sirt1 KO mice,
we evaluated, as a measure of sympathetic tone, uncoupling pro-
tein 1 (UCP1) mRNA expression in both groups of mice. We ob-
served that UCP1 level was signiﬁcantly elevated in the brown
adipose tissue (BAT) of AgRP-Sirt1 KO animals compared with
controls (Fig. S10), and in vivo treatment with sympathetic blockers
propranolol and SR59230A reduced UCP1 expression to a level
comparable to that of control mice (Fig. S10). Interestingly, the
analysis of the effect of sympathetic blockade on the immune
phenotype of both WT and AgRP-Sirt1 KO mice revealed that
propranolol and SR59230A in vivo treatment was able to reverse
the impaired suppressive function of Treg cells (Fig. 3B). In
agreement with the impaired suppressive capacity, puriﬁed Treg
cells from AgRP-Sirt1 KO mice produced a signiﬁcantly lower
amount of regulatory anti-inﬂammatory cytokines such as IL-10
and TGF-β (Fig. 3C), both central cytokines involved in Treg
suppressive functions (21, 22). This suggests that the observed
impairmentmight be in part responsible for the altered suppressive
activity detected in AgRP-Sirt1 KO mice, in terms of inhibition of
proinﬂammatory secretion. Notably, no difference in IL-4 pro-
duction was detected (Fig. 3C). Again, in vivo sympathetic
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Fig. 2. Effect of selective Sirt1 ablation in AgRP neurons on
the control of CD4+ T-cell functions. (A) Proliferative re-
sponse of lymph node-derived T cells from WT (black col-
umns) and AgRP-Sirt1 KO (gray columns) mice, stimulated or
not with anti-CD3 for 48 h. Data are shown asmean± SD (n=
5 mice/group; *P < 0.0001, **P < 0.05). (B) IL-2, IL-6, IL-17,
IFN-γ, TNF-a, IL-4, IL-5, and IL-10 production in cell superna-
tant from lymph node-derived T cells from WT (black col-
umns) and AgRP-Sirt1 KO (gray columns) mice. The data are
shown as mean ± SD (n = 5 mice/group; *P < 0.001, **P <
0.05; NS, not signiﬁcant). (C ) Activation markers (CD25,
CD54, and CD49d) expression gated on CD4+ T cells fromWT
(black histogram) and AgRP-Sirt1 KO (gray histogram) mice,
stimulated with anti-CD3 after 36 h of culture. For each
molecule the fold induction upon anti-CD3 stimulation is
shown. Representative of ﬁve independent experiments. (D)
Immunoblot for P-ERK1/2, ERK1/2, P-S6, S6, p27Kip1, and tu-
bulin on lymph node-derived T cells fromWT andAgRP- Sirt1
KOmice, stimulated or not with anti-CD3 for 1 h. The graphs
show the relative densitometric protein quantiﬁcation of
P-ERK 1/2, P-S6, and p27Kip1 speciﬁcally of the gels shown in
Fig. 1D from WT (black columns) and AgRP-Sirt1 KO (gray
columns)mice. One representative out of three independent
experiments.
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blockade was able to restore the production of anti-inﬂammatory
IL-10 and TGF-β from AgRP-Sirt1 KO mice (Fig. 3C).
AgRP-Sirt1 KO Mice Display Enhanced Delayed-Type Hypersensitivity
Responses and Increased EAE Susceptibility to Myelin Autoantigens.
To determine the nature of the in vivo adaptive T-cell response in
mutant Agrp-Sirt1 KO mice in the context of CD4+-mediated
T-cell responses and autoimmune disease susceptibility, we induced
EAE and measured delayed-type hypersensitivity (DTH) re-
sponses against the myelin oligodendrocytic peptide MOG35–55.
Seven days after priming with theMOG35–55 peptide emulsiﬁed in
CFA, mice were challenged with 50 μg of MOG35–55 injected in-
tradermally in the footpad. The degree of local footpad swelling was
measured as an indication of the DTH reaction. Typical DTH ki-
netics were observed and footpad swelling peaked between 48 and
72 h and subsided after 96 h (Fig. 4A). DTH responses to the
MOG35–55-priming epitope were signiﬁcantly enhanced in AgRP-
Sirt1 KO mice compared with littermate controls (Fig. 4A). In ad-
dition, mice were monitored up to 30 d for clinical signs of EAE. In
agreementwith theobserved enhancedDTH reactivity, AgRP-Sirt1
KO mice showed an increased EAE susceptibility compared with
normal control mice (Fig. 4B), as shown by increased inﬂammatory
inﬁltrates of the CNS (Fig. 4 C and D). These data were associated
with increased MOG35–55-speciﬁc proliferation and inﬂammatory
cytokine production by AgRP-Sirt1 KO mice (Fig. 4 E and F).
Discussion
Nutritional status, andmetabolism in general, can affect peripheral
immune responses. For example, fuel availability, through regula-
tion of adipocytokines, controls inﬂammatory immune responses
(23, 24). In this context, leptin, the adipocyte-derived hormone,
seems to play an important role. Elevated leptin levels promote
a proinﬂammatory state, an effect that likely relies on both central
and peripheral modes of action (25–28). In contrast, fasting or
chronic calorie restriction promotes anti-inﬂammatory processes,
which occur while circulating leptin levels are low (25–28).
In the present study, we found that impairment of AgRP neu-
ronal responses to metabolic cues by cell-speciﬁc knockdown of
Sirt1 (4) resulted in a proinﬂammatory state, in which effector
T-cell function is enhanced while regulatory T-cell activity is di-
minished, as suggested not only by an enhanced proinﬂammatory
cytokine production in vitro, but also by an increased in vivo re-
activity to self-myelin antigens. This proinﬂammatory immune
phenotype emerged in animals despite the fact that they are leaner
and have lower circulating leptin levels compared with their con-
trol littermates (4). These results suggest that the hypothalamic
melanocortin system can exert control over peripheral immune
responses independent of circulating leptin levels or adiposity.
AgRP neurons are crucial for hunger and adaptation to low
energy availability (1, 2). Their primary actions on feeding, energy
expenditure, and glucose metabolism are thought to be mediated
by their GABAergic efferents to various hypothalamic and extra-
hypothalamic sites as well as via AgRP’s effect on themelanocortin
4 receptors (29, 30). For feeding behavior, AgRP efferents in the
parabrachial nucleus and paraventricular hypothalamic nucleus
have been emphasized. However, there is an important role at-
tributed to AgRP efferent-targeted arcuate nucleus proopiomela-
nocortin (POMC) neurons in many endocrine and autonomic
effects of the melanocortin system (31–34). Indeed, we found that
selective Sirt1 knockout in AgRP neurons, through impairing
AgRP neuronal excitability, can disinhibit POMC neurons, leading
to decreased feeding and increased energy expenditure of these
animals (4). An increase in POMC neuronal activity can lead to
elevated sympathetic tone through direct POMC efferents in the
thoracic segments of the spinal cord. Because the immune system is
under sympathetic control (35), we suggest that the altered im-
mune phenotype observed in our AgRP-Sirt1 KOmice originated,
at least in part, from the activity of the disinhibited POMCneurons.
In line with this, we observed that UCP1 mRNA is signiﬁcantly
elevated in the BAT of AgRP-Sirt1 KO animals compared with
littermate controls, suggesting an elevated sympathetic tone of
these animals (Fig. S10). We then showed that in vivo sympathetic
blockade abolished the difference inUCP1mRNA levels as well as
in suppressive capacity and cytokine production by Treg cells in
AgRP-Sirt1 KO and control mice. This information, together with
a recent paper by Luquet and coworkers (36), conﬁrms our
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Fig. 3. Effect of selective Sirt1 ablation in AgRP
neurons in the control of Treg cell functions. (A)
Flow cytometry ex vivo analysis of PCNA (Left) and
PS6 (Right) in Treg cells from the lymph nodes of WT
and AgRP-Sirt1 KO mice. (n = 3 mice/group, repre-
sentative of three independent experiments). (B)
Proliferation, IL-2, IL-17, and IFN-γ production by
Teff cells in coculture with Treg cells from WT and
AgRP-Sirt1 KO mice treated or not in vivo with pro-
pranolol and SR59230A, upon anti-CD3/CD28 stim-
ulation. The data are shown as mean ± SD (n = 5
mice/group; *P< 0.0001, **P< 0.05). (C) IL-10, TGF-β,
and IL-4 production in puriﬁed Treg cells from WT
(black columns) and AgRP-Sirt1 KO (gray columns)
mice treated or not in vivo with propranolol and
SR59230A, upon anti-CD3/CD28 stimulation. (n = 5
mice/group; *P < 0.001; NS, not signiﬁcant).
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suggestion that the sympathetic nervous system plays a crucial role
in mediating the effect of impaired AgRP neuronal activity on the
immune system. Elevated POMC tone in lean AgRP-Sirt1 KO
animals reﬂects their “central perception” of relative satiety
compared with control littermates. This is normally characteristic
of overfed mice with elevated leptin levels, a state that also sup-
ports inﬂammation, enhanced activation of CD4+ T cells, and
a qualitative and quantitative reduction in Treg cells (19, 37, 38).
Our results are also in line with the overall effect of sirtuins on the
immune system (16) and suggest that AgRP neurons represent an
important site of action of sirtuins to exert a systemic effect during
low energy availability on the immune system. Finally, because the
intracellular second messenger cAMP has a key role in mediating
suppressive activity of Treg cells (39), in our system it would be
interesting to monitor on hypothalamic neurons some cAMP-
activating neurotransmitters such as the pituitary adenylate cy-
clase-activating polypeptide (39). Altered levels of suchmolecules
could, at least in part, explain some of the results we observed in
our AgRP-Sirt1 KO mice, particularly in the context of the ob-
served reduced suppressive capacity of Treg cells.
In summary, our observations provide a unique role for hy-
pothalamic AgRP neurons in integrative physiology. Our data
support the notion that the CNS can affect immune functions
(40, 41), which can supersede the predicted effects of circulating
metabolic hormones, such as leptin. These results, together with
our recent demonstration of speciﬁc behavioral and metabolic
phenotypes of AgRP-Sirt1 KO animals (3, 4), suggest that traits
of altered motivated behaviors and basic metabolic parameters
can be predictors of adaptive immune system phenotypes.
Materials and Methods
Mice. We used the knockdown model of Sirt1 in the NPY/AgRP neurons pre-
viously described (4). Brieﬂy, we used Cre/Lox technology to knock down the
catalytic domain of Sirt1 in this population of cells. Transgenicmice expressing
Cre recombinase selectively in the AgRP-expressing cells (42–44) were bred
with mice harboring a targeted mutant Sirt1 allele (Sirt1loxP) (43). The
Sirt1loxP/loxPmice contain loxP sequences ﬂanking exon 4 of the Sirt1 gene,
which encodes 51 amino acids of the Sirt1 catalytic domain. When bred with
the AgrpCre+ mice, the deleted Sirt1 allele (Sirt1Δex4) transcribes a mutant
protein that has no apparent residual Sirt1 activity or dominant negative
effects (45, 46). We describe our data by referring to control (littermate Cre
controls) and AgRP-Sirt1 KO mice. All animals were kept in temperature- and
humidity-controlled rooms, in a 12/12-h light/dark cycle, with lights on from
7:00 AM to 7:00 PM. Food and water were provided for ad libitum con-
sumption. All of the experiments were performed in animals 8–10 wk old.
Experimentswere conducted in accordancewith the animalwelfare guidelines
under an approved protocol of the Istituto Superiore di Sanità, Roma, Italy.
Induction of EAE and DTH Responses (Footpad-Swelling Assay). For actively
induced EAE, mice were immunized s.c. in the ﬂank with 100 μL of CFA (Difco
Laboratories) emulsiﬁed with 200 μg of MOG35–55 peptide on day 0, and
with 200 ng of pertussis toxin (Sigma) i.p. on days 0 and 1. Individual mice
were observed daily for clinical signs of disease for up to 30 d after immu-
nization. Mice were weighed and scored daily according to the clinical se-
verity of symptoms on a scale of 0–6 by an experimenter “blinded” to their
identity, with 0.5 points for intermediate clinical ﬁndings, as follows: grade 0,
no abnormality; grade 0.5, partial loss of tail tonicity, assessed by inability to
curl the distal end of the tail; grade 1, reduced tail tone or slightly clumsy gait;
grade 2, tail atony, moderately clumsy gait, impaired righting ability, or any
combination of these signs; grade 3, hind-limb weakness or partial paralysis;
grade 4, complete hind-limb paralysis or forelimb weakness; grade 5, tetra-
plegia or moribund state; grade 6, death. The data were plotted as daily mean
clinical scores for all animals in a particular treatment group. Scores of
asymptomatic mice (score = 0) were included in the calculation of the daily
mean clinical score for each group. The brains and spinal cords were dissected
20 d (peak of disease) after immunization and ﬁxed in 10% formalin. Parafﬁn-
embedded sections, 5 μm thick, from brains and spinal cords were stained with
hematoxylin–eosin and investigated for evidence of inﬂammation. Sections
from 4 to 10 segments per mouse were examined by one investigator blinded
to the group’s identity using a published scoring system for inﬂammation (47).
DTH responses to MOG35–55 peptide during induction of disease were
also quantitated using a time-dependent (12–96 h) footpad-swelling assay.
Brieﬂy, mice previously sensitized with MOG35–55 in CFA on day 0 were
challenged by s.c. injection of 50 μg of MOG35–55 (in 50 μL of PBS) into the
right hind footpad 10 d later. PBS alone was injected into the left footpad to
serve as control for measurements. Footpad thickness was measured 0, 12,
24, 48, 72, and 96 h after challenge by an experimenter blinded to sample
identity, using a caliper-type engineer’s micrometer. Information on ﬂow
cytometric analysis, proliferation assays, cytokines measurement, Western blots
and biochemical analyses, in vivo treatment with propranolol and SR59230A,
and real-time PCR analysis can be bound in SI Materials and Methods.
Statistical Analyses. The Mann–Whitney U test was used for unrelated two-
group analyses and the Kruskal–Wallis ANOVA test for three or more groups,
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Fig. 4. Effect of selective Sirt1 ablation in AgRP neurons on DTH responses and EAE susceptibility. (A) Seven days after sensitization withMOG35–55 in CFA, mice
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using StatView software (Abacus Concepts Inc.). Results are expressed as
mean ± SD. P values < 0.05 were considered statistically signiﬁcant.
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